98 results
8-K/A
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
7:18pm
compared to
the prior year was primarily driven by salary and bonus severance costs for former executives of $0.6 million, an increase of $0.4 million
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
4:00pm
to
the prior year was primarily driven by salary and bonus severance costs for former executives of $0.6 million, an increase of $0.4 million due
8-K
EX-99.1
tfex vuyjkcrc8u
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
8-K
EX-99.1
exptyo6zrtory4iqalu0
14 Aug 23
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:30am
8-K
EX-99.1
thaig6w
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
8-K
EX-99.1
qobptul9mjz1wo41g
7 Nov 22
Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
g7qxa5u054ct4 bv2
8 Aug 22
Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
wla07zv9kg kz6
9 May 22
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:00pm